Gliclazide 60mg MR

Gliclazide 60mg MR is a modified-release oral antidiabetic medication commonly prescribed for the treatment and management of type 2 diabetes mellitus. It belongs to the sulfonylurea class of medicines and works by stimulating insulin secretion from the pancreas to help lower blood glucose levels effectively. The modified-release formulation gradually releases the medication throughout the day, supporting stable and sustained glucose control.

Gliclazide 60mg MR is often recommended when lifestyle modifications such as diet, exercise, and weight management alone are insufficient to maintain healthy blood sugar levels. Long-term glucose control is essential for reducing complications affecting the kidneys, nerves, eyes, and cardiovascular system.

Patients exploring diabetes treatment options may also review Gliclazide 30mg MR as a related modified-release therapy for physician-supervised blood sugar management.

Healthcare professionals frequently consult Mayo Clinic – Type 2 Diabetes Treatment and NHS – Gliclazide Overview for evidence-based diabetes care recommendations and updated medication safety guidance.

Mechanism of Action

Insulin Secretion Enhancement

Gliclazide 60mg MR stimulates pancreatic beta cells to release insulin, helping move glucose from the bloodstream into body tissues where it can be used for energy.

Modified-Release Benefits

The MR formulation gradually releases medication throughout the day, helping maintain stable blood sugar levels and reducing glucose fluctuations in patients with type 2 diabetes mellitus.

Patients comparing diabetes management therapies may also evaluate Gliclazide 30mg MR for additional sustained-release blood sugar control options.

Approved Medical Uses

Type 2 Diabetes Mellitus

Gliclazide 60mg MR is primarily prescribed for adults with type 2 diabetes mellitus requiring improved glycemic control beyond lifestyle modifications alone.

Combination Therapy

The medication may be used alone or in combination with other diabetes medications depending on individual patient treatment requirements.

Dosage and Administration

Standard Dosage

The dosage should always be determined by a healthcare provider based on blood glucose levels, treatment response, and overall health condition. Tablets are generally taken with breakfast or the first meal of the day.

Importance of Meal Consistency

Patients are encouraged to maintain regular meals and consistent blood sugar monitoring during therapy to help reduce hypoglycemia risk.

Missed Dose Instructions

If a dose is missed, it should be taken when remembered unless it is close to the next scheduled dose. Double dosing should be avoided.

Clinical Effectiveness

Clinical studies have demonstrated that Gliclazide 60mg MR effectively lowers blood glucose and HbA1c levels in patients with type 2 diabetes mellitus. Improved glycemic control may help reduce long-term diabetes complications and support better metabolic health outcomes.

Healthcare providers may recommend therapies such as Gliclazide 30mg MR alongside individualized diabetes management strategies depending on patient-specific needs.

Safety and Side Effects

Common Side Effects

Some commonly reported side effects include:

• Low blood sugar (hypoglycemia)
• Dizziness
• Headache
• Nausea
• Mild weight gain
• Stomach discomfort

Most side effects are manageable with proper medical supervision.

Serious Risks

Hypoglycemia

Low blood sugar may occur if meals are skipped, exercise increases significantly, or alcohol is consumed excessively during treatment.

Allergic Reactions

Rare allergic reactions such as rash, itching, or swelling may require immediate medical attention.

Healthcare professionals frequently reference Mayo Clinic – Type 2 Diabetes Treatment and NHS – Gliclazide Overview for updated medication safety and diabetes care guidance.

Contraindications and Precautions

Gliclazide 60mg MR should be used cautiously in patients with:

• Severe kidney disease
• Liver impairment
• History of severe hypoglycemia
• Type 1 diabetes mellitus
• Pregnancy or breastfeeding unless medically advised

Routine glucose monitoring remains essential throughout treatment.

Drug Interactions

Gliclazide 60mg MR may interact with:

• Insulin
• Other antidiabetic medications
• Alcohol
• Certain antibiotics
• Blood pressure medications

  FAQs